Key Insights
The New Zealand diabetes devices market, valued at approximately NZD 435.36 million in 2025, is projected to experience steady growth, driven by rising diabetes prevalence, an aging population, and increasing adoption of advanced monitoring and management technologies. The market's Compound Annual Growth Rate (CAGR) of 3.30% from 2025 to 2033 indicates a consistent expansion, albeit moderate, suggesting a relatively mature market with established players. Key segments include self-monitoring blood glucose (SMBG) devices, continuous glucose monitoring (CGM) systems, insulin pumps, and various insulin delivery systems (syringes, pens, cartridges, infusion sets). The increasing preference for CGM systems over SMBG devices, due to their enhanced convenience and real-time data provision, is a significant market trend. This is further bolstered by technological advancements leading to smaller, more user-friendly devices and improved data integration capabilities. While regulatory hurdles and high device costs may pose some restraints, the overall market outlook remains positive, fueled by government initiatives promoting diabetes management and the growing awareness of the benefits of advanced technologies for improved patient outcomes.
Growth within specific segments will likely vary. CGM systems are expected to exhibit faster growth than SMBG devices, driven by technological improvements and increased patient demand for continuous monitoring. Similarly, insulin pump adoption is anticipated to grow steadily due to the advantages of automated insulin delivery for better glycemic control, though uptake may be slower due to higher initial costs. The market will continue to see intense competition among major players like Roche, Abbott, Medtronic, and Novo Nordisk, who are focused on innovation and product differentiation, alongside smaller, specialized companies focusing on niche areas within the market. The increasing focus on data analytics and telehealth solutions, further integrated with device functionalities, also presents significant opportunities for market expansion in the coming years.

New Zealand Diabetes Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the New Zealand diabetes devices market, offering invaluable insights for industry professionals, investors, and strategic decision-makers. We delve into market dynamics, growth trends, key players, and future opportunities within the parent market of healthcare devices and the child market of diabetes management solutions. The study period spans from 2019 to 2033, with 2025 serving as the base and estimated year. The forecast period covers 2025-2033, and the historical period encompasses 2019-2024. Market values are presented in million units.
New Zealand Diabetes Devices Market Dynamics & Structure
This section analyzes the competitive landscape, technological advancements, regulatory environment, and market trends within the New Zealand diabetes devices market. We explore market concentration, assessing the market share of key players like Roche, Ypsomed, Abbott, Eli Lilly, Sanofi, Medtronic, Tandem, Insulet, Lifescan (Johnson & Johnson), Becton Dickinson, Novo Nordisk, and Dexcom. Our analysis includes:
- Market Concentration: Analysis of market share distribution among top players, revealing the level of competition and potential for disruption. (e.g., Top 3 players hold xx% of the market in 2025).
- Technological Innovation: Examination of the role of continuous glucose monitoring (CGM) technology, insulin pump advancements, and smart device integration in driving market growth. We evaluate the impact of technological innovation on market segmentation and consumer preferences.
- Regulatory Landscape: Assessment of the regulatory framework governing medical device approvals and market access in New Zealand. The influence of regulatory changes on market dynamics will be highlighted.
- Competitive Substitutes: Analysis of alternative diabetes management approaches and their impact on the market share of different device types. (e.g., lifestyle changes, alternative medications).
- End-User Demographics: Detailed profiling of the diabetic population in New Zealand, considering age, type of diabetes, and treatment preferences. This will include analysis of prevalence rates and their impact on market demand.
- M&A Activity: Review of recent mergers, acquisitions, and partnerships within the New Zealand diabetes devices market, assessing their impact on market consolidation and innovation. (e.g., xx M&A deals were recorded between 2019 and 2024).
New Zealand Diabetes Devices Market Growth Trends & Insights
This section leverages extensive market research data to provide a comprehensive analysis of market size evolution, adoption rates, technological disruptions, and consumer behavior shifts from 2019 to 2033. Key metrics, such as CAGR and market penetration, are incorporated to provide in-depth insights. The analysis includes detailed examination of market drivers and restraints, impacting the overall growth of the market. Factors like increasing prevalence of diabetes, technological advancements, government initiatives and rising healthcare expenditure contribute to the market growth. However, high cost of devices and therapies, stringent regulatory processes and reimbursement challenges act as restraints to the market expansion.

Dominant Regions, Countries, or Segments in New Zealand Diabetes Devices Market
This section identifies the leading regions, countries, and segments within the New Zealand diabetes devices market, focusing on:
- Monitoring Devices: Self-monitoring blood glucose devices (SMBG) and continuous glucose monitoring (CGM) systems – value and volume data from 2017-2028. Analysis of market share and growth potential for each segment, identifying the dominant regions and factors driving their success.
- Lancets: Value and volume data (2017-2028). Analysis of market trends and growth drivers for lancets, emphasizing regional variations in demand.
- Management Devices: Insulin pumps, insulin syringes, insulin cartridges, and disposable pens – value and volume data from 2017-2028. A breakdown of market share by device type, outlining regional variations and key growth drivers.
- Infusion Sets: Value and volume data (2017-2028). Assessment of market trends and growth potential, focusing on factors driving regional variations.
Each segment analysis will include identification of the dominant region(s) within New Zealand, accompanied by an explanation of the underlying factors contributing to their dominance. (e.g., Auckland may dominate due to higher population density and healthcare infrastructure).
New Zealand Diabetes Devices Market Product Landscape
This section provides a concise overview of the product landscape, including descriptions of current product innovations, applications, and performance metrics. It emphasizes the unique selling propositions (USPs) of leading products and highlights key technological advancements impacting market dynamics.
Key Drivers, Barriers & Challenges in New Zealand Diabetes Devices Market
This section outlines the key drivers and challenges shaping the New Zealand diabetes devices market. Drivers might include rising diabetes prevalence, technological advancements, and government initiatives. Challenges might include high costs, reimbursement issues, and competition from alternative therapies. Quantitative data will be used to support the analysis where possible.
Emerging Opportunities in New Zealand Diabetes Devices Market
This section highlights emerging trends and untapped opportunities, such as the potential for telehealth integration, personalized medicine, and the adoption of innovative diabetes management solutions.
Growth Accelerators in the New Zealand Diabetes Devices Market Industry
This section examines the catalysts driving long-term growth, including technological breakthroughs, strategic partnerships, and market expansion strategies. The focus will be on factors that have the potential to significantly impact market trajectory over the long term.
Key Players Shaping the New Zealand Diabetes Devices Market Market
- Roche
- Ypsomed
- Abbott
- Eli Lilly
- Sanofi
- Medtronic
- Tandem
- Insulet
- Lifescan (Johnson & Johnson)
- Becton Dickinson
- Novo Nordisk
- Dexcom
7-2 Company Share Analysis will be included providing a detailed market share of each company.
Notable Milestones in New Zealand Diabetes Devices Market Sector
This section will list key events such as product launches, regulatory approvals, and significant partnerships, chronologically showcasing their impact on the market. (e.g., "October 2022: Abbott launches new CGM system in New Zealand.")
In-Depth New Zealand Diabetes Devices Market Market Outlook
This section summarizes the key growth accelerators and offers a perspective on the future market potential and strategic opportunities. The focus will be on projecting future market size and identifying promising areas for investment and growth.
New Zealand Diabetes Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-mon
- 1.1.1. Glucometer Devices
- 1.1.2. Test Strips
- 1.1.3. Lancets
-
1.2. Continuo
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-mon
-
2. Management Devices
-
2.1. Insulin Pump (Value and Volume, 2017 - 2028)
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes (Value and Volume, 2017 - 2028)
- 2.3. Insulin Cartridges (Value and Volume, 2017 - 2028)
- 2.4. Disposable Pens (Value and Volume, 2017 - 2028)
-
2.1. Insulin Pump (Value and Volume, 2017 - 2028)
New Zealand Diabetes Devices Market Segmentation By Geography
- 1. New Zealand

New Zealand Diabetes Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 3.30% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Rising diabetes prevalence
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. New Zealand Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-mon
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuo
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-mon
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump (Value and Volume, 2017 - 2028)
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes (Value and Volume, 2017 - 2028)
- 5.2.3. Insulin Cartridges (Value and Volume, 2017 - 2028)
- 5.2.4. Disposable Pens (Value and Volume, 2017 - 2028)
- 5.2.1. Insulin Pump (Value and Volume, 2017 - 2028)
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. New Zealand
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Roche
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Ypsomed
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Abbottt
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Eli Lilly
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Sanofi
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Medtronic
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Tandem
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Insulet
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Lifescan (Johnson &Johnson)
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Becton and Dickenson
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Novo Nordisk
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.12 Dexcom7 2 Company Share Analysi
- 6.2.12.1. Overview
- 6.2.12.2. Products
- 6.2.12.3. SWOT Analysis
- 6.2.12.4. Recent Developments
- 6.2.12.5. Financials (Based on Availability)
- 6.2.1 Roche
List of Figures
- Figure 1: New Zealand Diabetes Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: New Zealand Diabetes Devices Market Share (%) by Company 2024
List of Tables
- Table 1: New Zealand Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: New Zealand Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: New Zealand Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: New Zealand Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: New Zealand Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: New Zealand Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 7: New Zealand Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 8: New Zealand Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the New Zealand Diabetes Devices Market?
The projected CAGR is approximately 3.30%.
2. Which companies are prominent players in the New Zealand Diabetes Devices Market?
Key companies in the market include Roche, Ypsomed, Abbottt, Eli Lilly, Sanofi, Medtronic, Tandem, Insulet, Lifescan (Johnson &Johnson), Becton and Dickenson, Novo Nordisk, Dexcom7 2 Company Share Analysi.
3. What are the main segments of the New Zealand Diabetes Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 435.36 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Rising diabetes prevalence.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "New Zealand Diabetes Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the New Zealand Diabetes Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the New Zealand Diabetes Devices Market?
To stay informed about further developments, trends, and reports in the New Zealand Diabetes Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence